WebThe most common adverse events that occurred in greater than 5 percent of patients in the Repatha group were myalgia (13.8 percent Repatha; 21.9 percent ezetimibe), … WebStatin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectrum extending from myalgia with normal creatine kinase (CK) levels or asymptomatic hyperCKemia to potentially life-threatening rhabdomyolysis and necrotizing autoimmune myopathy. Myalgia with CK elevation is the most common presentation.
Did you know?
Common (1% to 10%): Back pain, myalgia, musculoskeletal pain, arthralgia (1.8%) Nervous system. Common (1% to 10%): Headache, dizziness. Uncommon (0.1% to 1%): Neurocognitive events (0.2%) Other. Common (1% to 10%): Influenza, fatigue (1.6%) Uncommon (0.1% to 1%): Contusion . Respiratory. … See more Along with its needed effects, evolocumab (the active ingredient contained in Repatha) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical … See more Some side effects of evolocumab may occur that usually do not need medical attention. These side effects may go away during treatment as … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Some … See more
WebJan 3, 2024 · Repatha is best administered into the front of your thighs or the lower part of your abdomen, avoiding the area around your belly button (stay an inch away from your belly button). If somebody else is giving you your injection they can also administer it into the outer area of your upper arm. WebAug 30, 2024 · Common side effects of Repatha include: runny or stuffy nose, upper respiratory tract infection, influenza, back pain, injection site reactions (redness, pain, and bruising), allergic reactions (rash and hives), cough, urinary tract infection, sinus infection, headache, muscle pain, dizziness, high blood pressure, diarrhea, and stomach upset.
WebRepatha (evolocumab) is a human monoclonal antibody that binds to proprotein convertase subtilisin kexin type 9 (PCSK9). PCSK9 binds to the low-density lipoprotein cholesterol (LDL-C) ... Myalgia: unexplained muscle discomfort often described as ‘‘flu-like’’ symptoms with normal CK level. The spectrum of myalgia complaints includes: WebThe most common adverse reaction that led to Repatha ® treatment discontinuation and occurred at a rate greater than placebo was myalgia (0.3% versus 0% for Repatha ® and placebo, respectively). Adverse reactions from a pool …
WebThe most common allergic reactions were rash (1.0% versus 0.5% for Repatha ® and placebo, respectively), eczema (0.4% versus 0.2%), erythema (0.4% versus 0.2%), and urticaria (0.4% versus 0.1%). Neurocognitive events were reported in less than or equal to 0.2% in Repatha ® -treated and placebo-treated patients.
WebThe most common adverse reaction that led to Repatha ® treatment discontinuation and occurred at a rate greater than placebo was myalgia (0.3% versus 0% for Repatha ® and placebo, respectively). Adverse reactions from a pool … bowel fapWebSep 15, 2024 · The most common adverse reactions that occurred at a rate greater than placebo were back pain (3.2% versus 2.9% for Repatha ® and placebo, respectively), arthralgia (2.3% versus 2.2%), and... bowel fit testWebOct 26, 2024 · However, many patients experience musculoskeletal side effects — myopathy, myalgia, myositis and, rarely, rhabdomyolysis — that either prevent them from using statins at all or limit their ability to tolerate a dosage necessary to achieve their cholesterol targets. bowel fatigueWebDefinition of Myalgia. Medical Editor: Charles Patrick Davis, MD, PhD; myalgia Myalgia: Pain in the muscles or within muscle 'tissue. SLIDESHOW Pictures of the 7 Riskiest Workout … bowel fit test resultsWebhomozygous familial hypercholesterolemia, adjunct tx. [10 yo and older] Dose: 420 mg SC qmo or 420 mg SC q2wk; Start: 420 mg SC qmo, may incr. to 420 mg SC q2wk after 12wk … bowel fit testing kitWebThe most common adverse reactions that occurred at a rate greater than placebo were back pain (3.2% versus 2.9% for Repatha ® and placebo, respectively), arthralgia (2.3% versus 2.2%), and myalgia (2.0% versus 1.8%). bowel failureWebFeb 1, 2024 · It is also used in patients with a heart and blood vessel disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. This medicine is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor. This medicine is available only with your doctor's prescription. bowel fat